Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Over one-third of participants had had inadequate responses or intolerance to at least 3 prior b/tsDMARDs.

Vagus Nerve Stimulation Yields Responses in Refractory Rheumatoid Arthritis

However, fewer patients experienced flares in the tofacitinib group than in the placebo group, among other positive findings.

Tofacitinib Not Superior to Placebo in Systemic Juvenile Arthritis Double-Blind Trial

Just discussed data from 2 studies demonstrating efficacy of AI assessment compared to clinician assessment.

Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment

Findings from the first and only controlled study for macrophage activation syndrome were presented at the ACR Convergence.

Emapalumab May Improve Response Rates in MAS Treatment

People who used GC for over 2 years and 3 years had elevated risks of CVD and infection-related mortality, respectively, that never returned to pre-GC use levels.

Glucocorticosteroid Use for Rheumatoid Arthritis Increases CVD, Infection Mortality Risk Even After Cessation 

While an effective and promising strategy for chronic pain relief, more research on long-term cannabis usage is needed. 

Study Finds Benefits and Risks in Cannabis Use for Rheumatoid Arthritis 

Highest responders on DAS28 also had significantly greater decreases in 12-hydroxyeicosatetraenoic than low responders. 

Lowering RA Disease Activity With Biologics Enhances Protective Cardiovascular PON1 Activity 

Veterans residing in rural areas were only 10% more likely to initiate biologic therapies than those residing in rural areas.

Rurality Does Not Account for Disparities in Veteran Care for Rheumatoid Arthritis

A new cohort study including over 6 million participants has found an increased likelihood of Behçet disease, alocpecia, bulbous pemphigoid and other disorders post-COVID infection.

Autoimmune/Inflammatory Tissue Disorders Associated With COVID-19 Infection

Week 156 efficacy and safety data from the FINCH 4 study are consistent with that seen in FINCH 1, 2, and 3.

Filgotinib Continues to Show Efficacy for RA in LTE Studies

The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.